Materials. All chemical reagents were purchased from commercial sources and used without further purification. -aminolevulinic acid hydrochloride and DNase I (20 U/L) were purchased from Cosmo Bio Co., Ltd (Tokyo, Japan) and Roche Diagnostics K. K. (Basel, Switzerland), respectively. 2-(Nmorpholino)ethanesulfonic acid (MES) was purchased from Dojindo Laboratories (Kumamoto, Japan). 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), ()-2-methyl-2,4-pentanediol (MPD), thrombin, were purchased from Sigma-Aldrich Co., (St. Louis, MO). H 2 O 2 , dithiothreitol (DTT), ethylene glycol, sodium dodecyl sulfate (SDS), cholic acid, isopropyl--D-thiogalactopyranoside (IPTG), kanamycin sulfate, and reduced glutathione were obtained from WAKO Pure Chemical Industries, Ltd (Osaka, Japan). The following chemicals were purchased from Nacalai Tesque Inc. (Kyoto, Japan): glycerol, potassium chloride, tris(hydroxymethyl)aminomethane, urea, hydrochloric acid, phosphoric acid, K 2 HPO 4 , ampicillin sodium salt, lysozyme, and phenylmethylsulfonyl fluoride.
P450BM3.
The gene of P450BM3 inserted into pT7 was modified. The codon for Gly456 was replaced with a stop codon by mutagenesis with the primers 5'-CCGCTTTAGGGTATTCCTTCA-3' (forward) and 5'-ACCCTAAAGCGGAATTTTTTTGGATTT-3' (reverse). The transformed Escherichia coli BL21(DE3) were cultivated in LB medium supplemented with 100 μg/ml ampicillin at 37 C. At log phase, -aminolevulinic acid was added at OD 600 = 0.5 to a final concentration of 0.5 mM. IPTG was added to a final concentration of 1 mM at OD 600 = 0.8 and the cultivation proceeded at 20 C for 10 h. The harvested cells were collected by centrifugation and stored at -80 C. The frozen cells were suspended in 20 mM Tris-HCl buffer (pH 7.4) containing 1 mM DTT, 1 mM EDTA. After sonication of the suspended cells, the supernatant was collected by centrifugation. The solution was loaded on an anion exchange column (DE52, Whatman) and the column was washed with 20 mM Tris-HCl buffer (pH 7.4) containing 1 mM DTT, 1 mM EDTA, and 50 mM KCl. A recombinant form of P450BM3
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was eluted with 20 mM Tris-HCl buffer (pH 7.4) containing 1 mM DTT, 1 mM EDTA, and 50-500 mM KCl. The fractions were collected and concentrated to less than 5 ml by centrifugation using Amicon Ultra filter units (Millipore, Co., Cork, Ireland). The concentrated sample was loaded onto an S-200 Sephacryl HR column (GE Healthcare UK Ltd) for size exclusion chromatography using BioAssist eZ (TOSOH Corp.). The purity of P450BM3 was examined using SDS-PAGE (Fig. S1 ) and the concentration of P450BM3 was determined by pyridine hemochromogen method. 3 T268E mutant was prepared by the same procedure to the wild-type.
P450cam.
E. coli BL21(DE3) transformed with pET-11a containing the gene of P450cam WT were cultivated in LB medium supplemented with 100 μg/ml ampicillin at 37 C. At log phase, -aminolevulinic acid was added at OD 600 = 0.6 to a final concentration of 0.5 mM. IPTG was added to a final concentration of 1 mM at OD 600 = 0.8 and the cultivation proceeded at 25 C for 12 h. The harvested cells were collected by centrifugation and stored at -80 C. The frozen cells were suspended in 50 mM potassium phosphate buffer (pH 6.0) containing 1mM camphor.
After sonication of the suspended cells, the supernatant was collected by centrifugation. The solution was loaded on an anion exchange column (DE52, Whatman) and the column was washed with 50 mM potassium phosphate buffer (pH 6.0) containing 1mM camphor and 50 mM KCl. A recombinant form of P450cam was eluted with 50 mM potassium phosphate buffer (pH 6.0) containing 1mM camphor and 300 mM KCl. The fractions were collected and concentrated to less than 5 ml by centrifugation using Amicon Ultra filter units (Millipore, Co., Cork, Ireland). The concentrated sample was loaded onto DEAE 650S (TOSOH) and the column was washed with 50 mM potassium phosphate buffer (pH 6.0) containing 1mM camphor and 50 mM KCl and eluted with 50 mM potassium phosphate buffer (pH 6.0) containing 1mM camphor and 300 mM KCl. The concentrated sample was loaded onto an S-200 Sephacryl HR column (GE Healthcare UK Ltd) for size exclusion chromatography using BioAssist eZ (TOSOH Corp.). The purity of P450cam was examined using SDS-PAGE (Fig. S1 ) and the concentration of P450cam was determined by pyridine hemochromogen method. T252E mutant was prepared by the same procedure to wild-type.
CYP119.
The synthetic gene (codon optimized for expression in E. coli.) obtained from Eurofins was cloned into pACYCDuet-1 vector. E. coli BL21(DE3) transformed with pACYCDuet-1 harboring CYP119 gene was cultivated in LB medium supplemented with 25 μg/ml chloramphenicol) at 37 C. At log phase, -aminolevulinic acid and IPTG (final concentration of 1 mM) was added at OD 600 = 0.9 and the cultivation proceeded at 30 C for 47 h. The harvested cells were collected by centrifugation and stored at -80 C. The frozen cells were suspended in 20 mM Tris-HCl buffer (pH 7.4) containing 1 mM DTT, 1 mM EDTA. After sonication of the suspended cells, the supernatant was collected by centrifugation. The solution was loaded on an anion exchange column (DE52, Whatman) and the column was washed with 50 mM potassium phosphate buffer (pH 6.0) containing 1mM camphor and 50 mM KCl. A recombinant form of P450cam was eluted with 50 mM potassium phosphate buffer (pH 6.0) containing 1mM camphor and 200 mM KCl. The concentrated sample was loaded onto Super Q (TOSOH) and the column was washed with 50 mM potassium phosphate buffer (pH 6.0) containing 1mM camphor and 50 mM KCl and eluted with 50 mM potassium phosphate buffer (pH 6.0) containing 1mM camphor and 300 mM KCl. The fractions were collected and concentrated to less than 5 ml by centrifugation using Amicon Ultra filter units (Millipore, Co., Cork, Ireland). The concentrated sample was loaded onto an S-200 Sephacryl HR column (GE Healthcare UK Ltd) for size exclusion chromatography using BioAssist eZ (TOSOH Corp.). The purity of CYP119 was examined using SDS-PAGE (Fig. S1 ) and the concentration of CYP119 was determined by pyridine hemochromogen method. Styrene oxidation. Styrene was purified by aluminum column chromatography to remove a polymerization inhibitor before measurements and used immediately after the purification. 4 Epoxidation of styrene was performed as follows. 
1-Methoxynaphthalene oxidation
The reaction was carried out in 100 mM potassium phosphate buffer (pH 7.0) with 0.5 μM of A245E mutant of P450 SPα , 0.5 mM of 1-methoxynaphthalene, and 0.5mM of H 2 O 2 for 1 min at 25 °C. After the reaction, the reaction mixture was extracted with chloroform. The extract was filtrated, transferred into a volumetric flask, and diluted to 5 mL. The catalytic activities for 1-methoxynaphthalene were determined by monitoring the absorption at 634.5 nm with a molar absorption coefficient of 18,900 M -1 cm -1 in chloroform. The initial turnover rates are averages of at least three measurements and are expressed in terms of micromoles of product per minute per micromole of P450.
Indole oxidation
The reaction was carried out in 100 mM potassium phosphate buffer (pH 7.4) containing 0.5 mM indole, 0.5 μM of A245E mutant of P450 SPα , 0.5mM of H 2 O 2 for 1 min at 25 °C. After the reaction, the mixture is extracted with chloroform to extract indigo from aqueous phase. The catalytic activity was determined by the absorbance of indigo at 605 nm with a molar absorption coefficient of 11,000 M -1 cm -1 and the turnover numbers were averaged of least three measurements and expressed in terms of micromolar of product per micromolar of P450 per minute.
Scheme S1
The hydroxylation reaction of indole and 1-methoxynaphtalen catalyzed by A245E mutant of P450 SPα giving indigo and Russig's blue, respectively. 
Myristic acid oxidation
The reaction mixture contained 0.1 M potassium phosphate (pH 7.4), 100 M myristic acid, 5μM P450BM3 or CYP119, and 20 mM H 2 O 2 in a total volume of 1 mL. The reaction mixture was incubated at 70 C for 1 min and then the reaction was quenched by adding 1 mL of dichloromethane. After the addition of palmitic acid as an internal standard, the products were extracted with dichloromethane. For derivatization of the extract, 50 L of N, Obis(trimethylsilyl)trifluoroacetamide (BSTFA) containing 1% trimethylsilylchlorosilane (TMCS) was added and the mixture was incubated in the dark at room temperature for 1 h. The derivatized products were analyzed using a GCMS-QP2010 SE (Shimadzu Corp., Kyoto, Japan) equipped with DB-624 capillary column (30 m  0.32 mm; Agilent Technologies, Inc., Santa Clara, CA) to identify the products. The GC/MS analytical conditions were as follows: column temperature, 80 C (2 min) to 10 C/min (17 min) to 250 C (15 min); injection temperature, 250 C; interface temperature, 250 C; ditecter temperature, 250 C; carrier gas, He; flow rate, 1.9 mL/min, mode, splitless mode. The amount of products was estimated based on decrease of myristic acid. All initial turnover rates are the average of at least three measurements. 
Camphor oxidation
The reaction mixture contained 100 mM potassium phosphate (pH 7.4), 100 M camphor, 10μM of P450 cam , and 20 mM H 2 O 2 in a total volume of 0.5 mL. The reaction mixture was incubated at 25 C for 1 min and then the reaction was quenched by adding 0.5 mL of ethyl acetate. After the addition of 1-nonanol as an internal standard, the products were extracted with ethyl acetate. The products were analyzed using a GCMS-QP2010 SE (Shimadzu Corp., Kyoto, Japan) equipped with DB-624 capillary column (30 m  0.32 mm; Agilent Technologies, Inc., Santa Clara, CA) to identify the products. The GC/MS analytical conditions were as follows: column temperature, 80 C (2 min) to 25 C/min (6.8 min) to 250 C (3 min); injection temperature, 250 C; interface temperature, 250 C; ditecter temperature, 250 C; carrier gas, He; flow rate, 1.9 mL/min, mode, splitless mode. The total amount of products was estimated based on decrease of camphor. All initial turnover rates are the average of at least three measurements. Data collection and refinement.
Crystals were flash-cooled in liquid nitrogen. X-ray diffraction data sets were collected on beam line BL26B1 equipped with RIGAKU Saturn A200 CCD detector at the RIKEN SPring-8 (Hyogo, Japan) with a 1.0 Å wavelength at 100 K. HKL2000 program 5 was used for integration of the diffraction intensities and scaling. The structure of mutants were solved by a molecular replacement using MolRep. 6 The model building and refinement were performed using COOT 7 and REFMAC5. 8 TLS refinement 9 was performed at the final stage of the refinement, defining each chain in the asymmetric unit as a separate TLS group. Structure validation was performed using PROCHECK. 10 The final refinement statistics are summarized in Table S1 . Structural analysis of P450 SP . The accessible channels were calculated using CAVER. 11 All protein Figures were depicted using PyMOL. 12
Fig. S9
The active site structures of R241E superposed on that of wild-type. The water molecule in wild-type coordinated to the heme iron is shown in blue sphere and the water molecule above the heme in R241E is shown in red sphere. 
